Table 3 To whom and at what point MOUD is available by type of medication
From: The impact of the opioid crisis on U.S. state prison systems
MOUD availability within state prison systems | Buprenorphine | Methadone | Naltrexone |
|---|---|---|---|
Available in the state system (n = 21 states) | 91% | 91% | 86% |
 Availability in prisons (n = 583 prisons) | 15% | 9% | 36% |
Medication provided to (n = 21): | |||
 Pregnant women | 81% | 86% | – |
 Pregnant women only | 38% | 57% | – |
 People who were already receiving the medication when admitted to prison | 52% | 38% | 38% |
 Individuals being released | 38% | 24% | 86% |
 Others (pregnant women those entering prison on it) | 38% | 29% | 43% |
Medication used for (n = 21): | |||
 Continuity of care | 91% | 86% | 38% |
 Induction and treatment during confinement | 29% | 33% | 48% |
 Managing acute or chronic pain | 24% | 20% | – |
 Pre-release induction | 38% | 24% | 86% |
Medication provided by (n = 21): | |||
 External contracted vendors on-site | 52% | 48% | 57% |
 External contracted vendors via transportation off site | 14% | 52% | 0% |
 Prison health care teams | 14% | 10% | 19% |
 Combination/Other | 14% | 5% | 10% |